The effects of postmenopausal hormone use on cataract: a meta-analysis.

BACKGROUND:Cataract is the leading cause of blindness worldwide. Many observational studies assessed the relationship between postmenopausal hormone replacement therapy (HRT) and risk of cataract development, but the reported results were controversial. The aim of present meta-analysis was to evalua...

Full description

Bibliographic Details
Main Authors: Kairan Lai, Jiantao Cui, Shuang Ni, Yidong Zhang, Jiliang He, Ke Yao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3813478?pdf=render
id doaj-ff03dce2ecc341eea6cb136549e7980b
record_format Article
spelling doaj-ff03dce2ecc341eea6cb136549e7980b2020-11-24T21:35:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7864710.1371/journal.pone.0078647The effects of postmenopausal hormone use on cataract: a meta-analysis.Kairan LaiJiantao CuiShuang NiYidong ZhangJiliang HeKe YaoBACKGROUND:Cataract is the leading cause of blindness worldwide. Many observational studies assessed the relationship between postmenopausal hormone replacement therapy (HRT) and risk of cataract development, but the reported results were controversial. The aim of present meta-analysis was to evaluate the association of postmenopausal hormone replacement therapy with risk of cataract development. METHODS:The eligible observational studies, including cross-sectional, case-control and cohort studies, were identified by searching PubMed and Embase during March of 2013. Either a fixed- or a random-effects model was used to calculate the pooled odds ratio (OR) with its 95% confidence interval (95%CI). Subgroup analysis on cataract types was performed. RESULTS:A total of four cohort and five case-control or cross-sectional studies were finally included into this meta-analysis. Overall, a significant decreased risk of developing any type of cataract was found in ever HRT group as compared with non-HRT group among cohort studies (OR 0.83; 95%CI: 0.71,0.97) and case-control or cross-sectional studies (OR 0.74; 95%CI: 0.59,0.93). Subgroup analysis on cataract types determined that the significantly decreased risk of nuclear cataract in current HRT group (OR 0.72; 95%CI: 0.61,0.85) and also a critically reduced risk of nuclear cataract in ever HRT group (OR 0.80; 95% CI: 0.64,1.01) were found among case-control or cross-sectional studies, as compared with non-HRT group. No association of HRT with risk of cortical and posterior subcapsular cataract was observed. CONCLUSIONS:The results of present meta-analysis indicate that postmenopausal hormone use may play a protective role in cataract development.http://europepmc.org/articles/PMC3813478?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kairan Lai
Jiantao Cui
Shuang Ni
Yidong Zhang
Jiliang He
Ke Yao
spellingShingle Kairan Lai
Jiantao Cui
Shuang Ni
Yidong Zhang
Jiliang He
Ke Yao
The effects of postmenopausal hormone use on cataract: a meta-analysis.
PLoS ONE
author_facet Kairan Lai
Jiantao Cui
Shuang Ni
Yidong Zhang
Jiliang He
Ke Yao
author_sort Kairan Lai
title The effects of postmenopausal hormone use on cataract: a meta-analysis.
title_short The effects of postmenopausal hormone use on cataract: a meta-analysis.
title_full The effects of postmenopausal hormone use on cataract: a meta-analysis.
title_fullStr The effects of postmenopausal hormone use on cataract: a meta-analysis.
title_full_unstemmed The effects of postmenopausal hormone use on cataract: a meta-analysis.
title_sort effects of postmenopausal hormone use on cataract: a meta-analysis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND:Cataract is the leading cause of blindness worldwide. Many observational studies assessed the relationship between postmenopausal hormone replacement therapy (HRT) and risk of cataract development, but the reported results were controversial. The aim of present meta-analysis was to evaluate the association of postmenopausal hormone replacement therapy with risk of cataract development. METHODS:The eligible observational studies, including cross-sectional, case-control and cohort studies, were identified by searching PubMed and Embase during March of 2013. Either a fixed- or a random-effects model was used to calculate the pooled odds ratio (OR) with its 95% confidence interval (95%CI). Subgroup analysis on cataract types was performed. RESULTS:A total of four cohort and five case-control or cross-sectional studies were finally included into this meta-analysis. Overall, a significant decreased risk of developing any type of cataract was found in ever HRT group as compared with non-HRT group among cohort studies (OR 0.83; 95%CI: 0.71,0.97) and case-control or cross-sectional studies (OR 0.74; 95%CI: 0.59,0.93). Subgroup analysis on cataract types determined that the significantly decreased risk of nuclear cataract in current HRT group (OR 0.72; 95%CI: 0.61,0.85) and also a critically reduced risk of nuclear cataract in ever HRT group (OR 0.80; 95% CI: 0.64,1.01) were found among case-control or cross-sectional studies, as compared with non-HRT group. No association of HRT with risk of cortical and posterior subcapsular cataract was observed. CONCLUSIONS:The results of present meta-analysis indicate that postmenopausal hormone use may play a protective role in cataract development.
url http://europepmc.org/articles/PMC3813478?pdf=render
work_keys_str_mv AT kairanlai theeffectsofpostmenopausalhormoneuseoncataractametaanalysis
AT jiantaocui theeffectsofpostmenopausalhormoneuseoncataractametaanalysis
AT shuangni theeffectsofpostmenopausalhormoneuseoncataractametaanalysis
AT yidongzhang theeffectsofpostmenopausalhormoneuseoncataractametaanalysis
AT jilianghe theeffectsofpostmenopausalhormoneuseoncataractametaanalysis
AT keyao theeffectsofpostmenopausalhormoneuseoncataractametaanalysis
AT kairanlai effectsofpostmenopausalhormoneuseoncataractametaanalysis
AT jiantaocui effectsofpostmenopausalhormoneuseoncataractametaanalysis
AT shuangni effectsofpostmenopausalhormoneuseoncataractametaanalysis
AT yidongzhang effectsofpostmenopausalhormoneuseoncataractametaanalysis
AT jilianghe effectsofpostmenopausalhormoneuseoncataractametaanalysis
AT keyao effectsofpostmenopausalhormoneuseoncataractametaanalysis
_version_ 1725944874439540736